Universidade Federal do Rio de Janeiro

Running trials

• Recruiting

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· Phase 3· Source

• Recruiting

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· Phase 3· Source

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Source

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Source

• Recruiting

  Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients

  NCT06593184· Source

• Recruiting

  Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients

  NCT07073287· Phase 2· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· Phase 2· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Source

• Active, not recruiting

  A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT03466411· Phase 2/3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Stroke2 recruiting
• Type 1 diabetes2 recruiting
• Liver cirrhosis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Indolent Non Follicular Lymphomas Prognostic Project

  NCT02904577· Source

Trial sites

• Universidade Federal do Rio de Janeiro2 trials
• Federal University of Rio de Janeiro2 trials
• Universidade Federal Do Rio de Janeiro4 trials
• Universidade Federal do Rio de Janeiro - Faculdade de Medicina4 trials

Conditions

Diseases this institution publishes on or runs trials for.

• HIV72 works · 0 trials
• Tuberculosis71 works · 0 trials
• Fatty liver disease (MASLD/MASH)27 works · 3 trials
• Amyloidosis18 works · 0 trials
• Pulmonary arterial hypertension12 works · 0 trials
• Hepatitis C9 works · 0 trials
• Primary biliary cholangitis6 works · 0 trials
• Fibromyalgia5 works · 0 trials